Nasopharyngeal Cancer

Cross-border pathways for NPC with precision radiotherapy support.

Cancer

Overview

Nasopharyngeal carcinoma (NPC) is particularly common among patients from Southeast Asia and southern China. EBV DNA serology, nasopharyngoscopy with biopsy, and MRI of the head and neck establish the stage.

Treatment pathways

Radiotherapy with concurrent chemotherapy is the standard of care; our team supports patients with precision target delineation, nutritional and swallowing support, and management of residual or recurrent disease, including seed implantation for selected local recurrences.

Cross-border care

Patients from Malaysia, Singapore, and Indonesia commonly combine treatment at home with review weeks in Guangzhou. Imaging transfer and remote case review can be arranged before travel.

Still have questions?

Reach our care team for personalized guidance on diagnosis, treatment, and insurance.

Request a Consultation
← Back to Cancer